NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,162,630 | +98763.1% | 11,414 | -2.1% | 0.05% | +4.1% |
| Q2 2023 | $1,176 | +6.6% | 11,653 | -2.8% | 0.05% | 0.0% |
| Q1 2023 | $1,103 | +3.4% | 11,987 | +1.9% | 0.05% | +2.1% |
| Q4 2022 | $1,067 | -99.9% | 11,766 | -0.4% | 0.05% | +9.1% |
| Q3 2022 | $898,000 | -10.3% | 11,816 | -0.3% | 0.04% | -4.3% |
| Q2 2022 | $1,001,000 | -12.4% | 11,850 | -9.0% | 0.05% | +2.2% |
| Q1 2022 | $1,143,000 | 0.0% | 13,028 | -0.4% | 0.04% | +9.8% |
| Q4 2021 | $1,143,000 | +6.3% | 13,074 | -0.5% | 0.04% | -2.4% |
| Q3 2021 | $1,075,000 | -13.4% | 13,145 | -3.3% | 0.04% | -10.6% |
| Q2 2021 | $1,241,000 | +2.1% | 13,595 | -4.3% | 0.05% | -4.1% |
| Q1 2021 | $1,215,000 | -11.6% | 14,208 | -2.4% | 0.05% | -15.5% |
| Q4 2020 | $1,375,000 | +0.9% | 14,563 | -7.1% | 0.06% | -7.9% |
| Q3 2020 | $1,363,000 | -5.1% | 15,675 | -4.7% | 0.06% | -11.3% |
| Q2 2020 | $1,436,000 | +6.6% | 16,447 | +0.6% | 0.07% | -10.1% |
| Q1 2020 | $1,347,000 | +5.9% | 16,347 | +21.6% | 0.08% | +21.5% |
| Q4 2019 | $1,272,000 | +2.9% | 13,438 | -5.6% | 0.06% | -3.0% |
| Q3 2019 | $1,236,000 | -9.1% | 14,230 | -4.4% | 0.07% | -9.5% |
| Q2 2019 | $1,359,000 | -21.9% | 14,879 | -17.8% | 0.07% | -22.1% |
| Q1 2019 | $1,740,000 | -3.1% | 18,097 | -13.5% | 0.10% | -12.8% |
| Q4 2018 | $1,796,000 | -9.7% | 20,923 | -9.4% | 0.11% | +3.8% |
| Q3 2018 | $1,989,000 | +1.1% | 23,087 | -11.3% | 0.10% | -4.5% |
| Q2 2018 | $1,967,000 | -1.1% | 26,033 | +5.8% | 0.11% | -3.5% |
| Q1 2018 | $1,988,000 | -5.8% | 24,596 | -2.1% | 0.11% | -0.9% |
| Q4 2017 | $2,110,000 | -16.3% | 25,135 | -14.4% | 0.12% | -20.1% |
| Q3 2017 | $2,521,000 | -10.4% | 29,366 | -12.9% | 0.14% | -13.8% |
| Q2 2017 | $2,815,000 | +5.6% | 33,728 | -6.1% | 0.17% | +3.7% |
| Q1 2017 | $2,666,000 | -5.6% | 35,902 | -7.4% | 0.16% | -9.0% |
| Q4 2016 | $2,823,000 | -25.7% | 38,753 | -19.5% | 0.18% | -25.9% |
| Q3 2016 | $3,800,000 | -15.5% | 48,115 | -11.7% | 0.24% | -16.4% |
| Q2 2016 | $4,496,000 | -9.2% | 54,482 | -20.3% | 0.29% | -10.1% |
| Q1 2016 | $4,950,000 | -73.6% | 68,333 | -68.7% | 0.32% | -72.9% |
| Q4 2015 | $18,757,000 | -8.0% | 217,990 | -1.8% | 1.18% | -10.0% |
| Q3 2015 | $20,395,000 | -8.8% | 221,884 | -2.4% | 1.31% | +0.5% |
| Q2 2015 | $22,356,000 | -1.3% | 227,336 | -1.0% | 1.30% | +0.9% |
| Q1 2015 | $22,650,000 | +2.4% | 229,689 | -3.8% | 1.29% | +3.8% |
| Q4 2014 | $22,116,000 | -2.0% | 238,674 | -0.5% | 1.24% | -3.0% |
| Q3 2014 | $22,577,000 | +1.0% | 239,842 | -2.9% | 1.28% | +3.8% |
| Q2 2014 | $22,357,000 | +3.8% | 246,952 | -2.5% | 1.23% | +2.3% |
| Q1 2014 | $21,531,000 | +5.1% | 253,246 | -0.6% | 1.20% | +4.5% |
| Q4 2013 | $20,484,000 | +11.0% | 254,842 | +5.9% | 1.15% | +1.4% |
| Q3 2013 | $18,452,000 | +7.6% | 240,539 | -0.8% | 1.14% | +2.5% |
| Q2 2013 | $17,153,000 | -1.1% | 242,582 | -0.4% | 1.11% | -0.9% |
| Q1 2013 | $17,351,000 | – | 243,550 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |